News

Researchers have discovered key human genomic signatures that could help explain why COVID-19 is severe in some people and mild in others.

Type 2 diabetes affects millions of people worldwide, and scientists have developed PATAS, a peptide that is part of a new class of antidiabetic drugs. PATAS can correct the metabolic abnormalities leading to type 2 diabetes and insulin resistance.

In a recent study, researchers shed some light on why the delivery of therapeutics to cells can be so difficult.

According to research, vaccination against COVID-19 had no impact on placenta health in pregnant women.

Physician-scientists have discovered that a gene called FOXR2 that is normally turned off in most tissues in the body is activated in at least 70 percent of cancer types and eight percent of all individual tumors.

Researchers have developed a biomimetic formulation using targeted delivery agents for glioblastoma multiforme therapy.

According to a study, vaccine-related fears reduce vaccination and fuel symptoms of dizziness and lightheadedness at the time of the injection.

Scientists have developed artificial intelligence software that can create proteins that may contribute to the development of vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

Researchers have discovered that cancer cells produce their own unique form of collagen that protects against immune responses. The abnormal collagen is fundamentally different from normal collagen, providing a highly specific target for therapy.

Study findings could help researchers better tailor their drug-delivery particles to specific types of cancer, or design new particles that take advantage of the biological features of particular types of cancer cells.